| Sign In to gain access to subscriptions and/or personal tools. |
School-Based Methylphenidate Placebo ProtocolsMethodological and Practical IssuesIrwin A. Hyman is a professor of school psychology at Temple University. In addition to his more recent research in ADHD, his interests lie in the areas of school violence, school discipline, and corporal punishment. Address: Irwin A. Hyman, 254 RHA, Temple University, Philadelphia, PA 19122.
Alexandra Wojtowicz is the clinical director of the ADHD Behavioral Learning Disabilities Center in Wilmington, Delaware.
Kee Duk Lee are doctoral students at Temple University.
Mary Elizabeth Haffner are doctoral students at Temple University.
Catherine A. Fiorello is an assistant professor of school psychology at Temple University. Her current interests include ADHD, cognitive assessment, and inclusion.
J. Jordan Storlazzi is a physician and founder of the ADHD Behavioral Learning Disabilities Center in Wilmington, Delaware, and is also a clinical associate professor of pediatrics at the Thomas Jefferson Medical College.
Joseph Rosenfeld is a professor and program director of the school psychology program at Temple University. His current interests include diagnostic assessment and ethical and legal issues. Around 1990, psychologists and educators began to notice increasing use of methylphenidate by students. Diagnosis of attention-deficit/hyperactivity disorder by family physicians and pediatricians was most commonly based on brief behavioral descriptions by parents and, infrequently, by use of rating scales. At that time, the present researchers began to explore the development of a school-based, methodologically sound, and inexpensive method of assessing the efficacy of stimulant medications, which would ensure reasonable compliance by teachers, parents, and students in monitoring the effects of medications and placebos. This article focuses on the methodological issues involved in choosing instruments to monitor behavior, once a comprehensive evaluation has suggested trials on Ritalin. Case examples illustrate problems of teacher compliance in filling out measures, supplying adequate placebos, and obtaining physician cooperation, and with the practical issue of providing adequate data without overwhelming the time and resources of participants. Emerging school-based methodologies are discussed with recommendations for future efforts.
Journal of Learning Disabilities, Vol. 31, No. 6,
581-594 (1998) This article has been cited by other articles:
|
|||||||||||||||||||||||||||

